Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18688)

• Formulation Name: Raloxifene 60 mg tablet
• Company: AvKARE; Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Raloxifene	(DMDKF3M)	Osteoporosis	FB83.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent